MyAverix Finance
US · Healthcare
Tvardi Therapeutics, Inc. (TVRD)
Biotechnology
Tvardi Therapeutics, Inc. (TVRD) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for TVRD
Tvardi Therapeutics, Inc. (TVRD) — FAQ
What is TVRD's P/E ratio?
The price-to-earnings (P/E) ratio for Tvardi Therapeutics, Inc. (TVRD) is 18.00 (data as of 2026-03-25).
Does Tvardi Therapeutics, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Tvardi Therapeutics, Inc. (TVRD). Check the MyAverix Finance app for the latest dividend data.
What sector is Tvardi Therapeutics, Inc. in?
Tvardi Therapeutics, Inc. (TVRD) is classified in the Healthcare sector (Biotechnology industry).
What exchange is TVRD listed on?
TVRD is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.